Literature DB >> 9339697

Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis.

J Pujol1, J Bello, J Deus, J L Martí-Vilalta, A Capdevila.   

Abstract

Depression is a common mood disturbance in multiple sclerosis (MS) patients. Epidemiologic data suggest a causative relationship between depressive symptoms and cerebral demyelination, although a specific lesion site responsible for depressed mood has not been identified. Given that depression in neurologic disease is closely related to frontal and temporal lobe damage, we focused our study on investigating the extent to which lesions in the white matter connecting both cerebral lobes may account for depressive symptoms in MS. Forty-five patients were assessed using the Beck Depression Inventory and an MRI protocol conceived to quantify lesions separately in the basal, medial, and lateral frontotemporal white matter. The presence of lesions in the left suprainsular white matter, the region that mainly includes the arcuate fasciculus, was specifically associated with depressive symptoms, accounting for a significant 17% of the depression score variance. Although a multifactorial origin is suspected for depression in MS, this finding gives support to the existence of a direct negative effect of demyelination on mood.

Entities:  

Mesh:

Year:  1997        PMID: 9339697     DOI: 10.1212/wnl.49.4.1105

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  Brain connectivity in late-life depression and aging revealed by network analysis.

Authors:  Rebecca A Charlton; Alex Leow; Johnson GadElkarim; Aifeng Zhang; Olusola Ajilore; Shaolin Yang; Melissa Lamar; Anand Kumar
Journal:  Am J Geriatr Psychiatry       Date:  2014-08-01       Impact factor: 4.105

2.  Effects of the anti-multiple sclerosis immunomodulator laquinimod on anxiety and depression in rodent behavioral models.

Authors:  Irit Gil-Ad; Ben H Amit; Liat Hayardeni; Igor Tarasenko; Michal Taler; Ravit Uzan Gueta; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2014-07-27       Impact factor: 3.444

Review 3.  White matter hyperintensities: from medical comorbidities to bipolar disorders and back.

Authors:  Eva Gunde; Ryan Blagdon; Tomas Hajek
Journal:  Ann Med       Date:  2011-07-13       Impact factor: 4.709

Review 4.  [Coexistent depressive and anxiety disorders in epilepsy and multiple sclerosis: a challenge to neuropsychiatric practice].

Authors:  Hans-Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2014-05-20

Review 5.  Imaging and depression in multiple sclerosis: a historical perspective.

Authors:  Fabio Giuseppe Masuccio; Giulia Gamberini; Massimiliano Calabrese; Claudio Solaro
Journal:  Neurol Sci       Date:  2021-01-07       Impact factor: 3.307

Review 6.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

7.  Computerized Cognitive Behavioral Therapy for Treatment of Depression in Multiple Sclerosis: A Narrative Review of Current Findings and Future Directions.

Authors:  Adrianna Ratajska; Jonathan Zurawski; Brian Healy; Bonnie I Glanz
Journal:  Int J MS Care       Date:  2019 May-Jun

8.  Fatigue in multiple sclerosis persists over time: a longitudinal study.

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

9.  White-matter tract integrity in late-life depression: associations with severity and cognition.

Authors:  R A Charlton; M Lamar; A Zhang; S Yang; O Ajilore; A Kumar
Journal:  Psychol Med       Date:  2013-09-16       Impact factor: 7.723

Review 10.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.